Solid Quarter at ALKS, View Backed (ALKS) (AMLN) (ELN) (JNJ)
Alkermes plc ( ALKS ) reported earnings of 28 cents per share (including depreciation and stock-based compensation expenses) in the first-quarter of fiscal 2013 (ended June 30, 2012). The Zacks Consensus Estimate was 10 cents per share. This was the third full quarter following the purchase of Elan Corporation ’s ( ELN ) drug delivery unit, Elan Drug Technologies (EDT). […]